for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Chongqing Zhifei Biological Prdct Co Ltd

300122.SZ

Latest Trade

107.94CNY

Change

0.39(+0.36%)

Volume

11,025,129

Today's Range

105.53

 - 

109.06

52 Week Range

103.78

 - 

231.19

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
107.55
Open
107.58
Volume
11,025,129
3M AVG Volume
255.94
Today's High
109.06
Today's Low
105.53
52 Week High
231.19
52 Week Low
103.78
Shares Out (MIL)
1,600.00
Market Cap (MIL)
172,080.00
Forward P/E
21.38
Dividend (Yield %)
0.46

Next Event

Q4 2021 Chongqing Zhifei Biological Products Co Ltd Earnings Release

Latest Developments

更多

Chongqing Zhifei Biological Products Sees 2021 Net Profit Up 200-220% Y/Y

Chongqing Zhifei's H1 Net Profit Up 264.9% Y/Y

Shenzhen Stock Exchange Filing Shows Block Trade Of Chongqing Zhifei's Shares Involving 1.3 Bln Yuan

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Chongqing Zhifei Biological Prdct Co Ltd

Chongqing Zhifei Biological Products Co., Ltd. is a China-based company principally engaged in the research, development, production, sale and distribution of vaccine products. The Company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevision and treatment of tuberculosis, viral vaccines for the prevention of rabies virus, influenza virus and other virus, general drugs and other biological products, among others. The Company is also involved in the agency sale of vaccines. The Company distributes its products in domestic market and to overseas markets, with Central China as its main market.

Industry

Biotechnology & Drugs

Contact Info

25F

No. 7, Jinyuan Road, Jiangbei District

CHONGQING, CHO

400020

China

+86.23.86358226

http://www.zhifeishengwu.com

Executive Leadership

Rensheng Jiang

Chairman of the Board, General Manager

Lingfeng Jiang

Vice Chairman of the Board, Deputy General Manager

Zhenjing Li

Chief Financial Officer, Deputy General Manager, Director

Xisheng Jiang

Deputy General Manager

Haitian Sun

Deputy General Manager

Key Stats

1.39 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2018

5.2K

2019

10.6K

2020

15.2K

2021(E)

25.7K
EPS (CNY)

2018

0.907

2019

1.479

2020

2.063

2021(E)

4.516
Price To Earnings (TTM)
18.65
Price To Sales (TTM)
6.63
Price To Book (MRQ)
10.86
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
3.94
LT Debt To Equity (MRQ)
0.56
Return on Investment (TTM)
77.63
Return on Equity (TTM)
42.78

Latest News

Latest News

UPDATE 1-China trials mixing of CanSinoBIO's and Zhifei Longcom's COVID-19 vaccines -data

Chinese researchers are testing the mixing of COVID-19 vaccine doses developed by CanSino Biologics and a unit of Chongqing Zhifei Biological Products, according to clinical trial registration data.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up